Search Within

Winston Wong

Formats
  1. Meeting Abstract (18)
  2. Journal Article (11)
  3. Review (2)
Groups
  1. Department of Medicine (26)
  2. Solid Tumor Oncology Division (26)
  3. Center for Pancreatic Cancer Research (19)
  4. Surgery (17)
  5. Head and Neck Service (16)
  6. Hematology-Oncology Fellows (14)

More Groups

People
  1. Alan Ho (13)
  2. Eric Sherman (13)
  3. Lara Dunn (12)
  4. David Pfister (10)
  5. Eileen O'Reilly (10)
  6. Nancy Lee (10)

More People

Years
  1. 2025 (4)
  2. 2024 (13)
  3. 2023 (3)
  4. 2022 (1)
  5. 2021 (1)
  6. 2020 (5)

More Years

Publications
  1. Journal of Clinical Oncology (11)
  2. Annals of Oncology (4)
  3. Oral Oncology (4)
  4. International Journal of Radiation Oncology, Biology, Physics (3)
  5. Cancer (2)
  6. Abdominal Radiology (1)

More Publications

Publishers
  1. American Society of Clinical Oncology (11)
  2. Elsevier Inc. (7)
  3. Oxford University Press (5)
  4. Nature Research (2)
  5. Wiley Blackwell (2)
  6. American Association for Cancer Research (1)

More Publishers

Results (31)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • A phase 1/1b study of lenvatinib and cetuximab in patients with recurrent/metastatic head and neck squamous cell carcinoma
    Journal Article

    Dunn, L. A.; Ho, A. L.; Michel, L. S.; Wong, W.; Eng, J.; Zhi, I.; Ng, K. K.; Kriplani, A.; Fetten, J.; Haque, S. S.; more...
    Oral Oncology (2025)

    Fulltext@MSK | Save
  • Osteoradionecrosis as a complication following post-operative intensity-modulated radiation therapy or proton therapy for oral cavity cancer
    Journal Article

    Treechairusame, T.; Singh, A.; Dee, E. C.; Oh, J. H.; Zhang, P.; Xiong, J.; Aliotta, E.; Safavi, A. H.; Wu, Y.; Caineng, C.; more...
    Oral Oncology (2025)

    Fulltext@MSK | Save
  • The role of circulating tumor DNA (ctDNA) in the treatment of human papilloma virus-positive (HPV+) oropharyngeal squamous cell carcinoma
    Review

    Qian, J. Y.; Chen, L.; Wong, W.; Morris, L. G. T.; Yacoub, I.; Lee, N. Y.; Ma, J.
    The Cancer Journal (2025)

    Fulltext@MSK | Save
  • Defining response-adapted surgery after neoadjuvant therapy in oral cavity cancer
    Review

    Cracchiolo, J. R.; Starc, M. T.; Wong, R. J.; Ho, A.; Ganly, I.; Pfister, D. G.; Lee, N.; Wong, W.; Tam, K.; Cohen, M. A.; more...
    Oral Oncology (2025)

    Fulltext@MSK | Save
  • Phase II study of PDR001 in combination with MAPK pathway inhibitors in patients with radioactive-refractory differentiated thyroid cancer (DTC)
    Meeting Abstract

    Wong, W.; Sherman, E. J.; Kriplani, A.; Michel, L.; Zhi, I.; Hung, T. K. W.; Dunn, L.; Grewal, R. K.; Krishnamoorthy, G.; Ostrovnaya, I.; more...
    Annals of Oncology (2024)

    Fulltext@MSK | Save
  • Phase II trial of ozuriftamab vedotin (BA3021), a conditionally active biologic (CAB)-ROR2-ADC, in patients with recurrent or metastatic squamous cell carcinoma of the head and neck (R/M SCCHN)
    Meeting Abstract

    Wong, W.; Adkins, D. R.; Misleh, J. G.; Lorch, J.; Grewal, J. S.; Russell, J.; Cetnar, J.; Ho, A. L.; Chen, K.; Aysola, K.; more...
    Annals of Oncology (2024)

    Fulltext@MSK | Save
  • Phase II multicenter, randomized, double-blind, placebo-controlled study evaluating the efficacy of HB-200 in patients with detectable TTMV-HPV DNA after definitive treatment for HPV16 + HNSCC
    Meeting Abstract

    Ho, A. L.; Riaz, N.; Pfister, D.; Wong, R.; Lee, N.; Sherman, E. J.; Haque, S.; Ostrovnaya, I.; Wong, W.
    Annals of Oncology (2024)

    Fulltext@MSK | Save
  • Neoadjuvant cemiplimab with platinum-doublet chemotherapy and cetuximab to de-escalate surgery and omit adjuvant radiation in locoregionally advanced head & neck squamous cell carcinoma (HNSCC)
    Meeting Abstract

    Dunn, L.; Cracchiolo, J.; Ho, A. L.; Sherman, E. J.; Ganly, I.; Ghossein, R.; Cohen, M.; Wong, W.; Desilets, A.; Michel, L.; more...
    Annals of Oncology (2024)

    Fulltext@MSK | Save
  • Long-term results of external beam radiation therapy (RT) with or without concurrent chemotherapy in loco regionally advanced or recurrent differentiated thyroid cancer (DTC)
    Meeting Abstract

    Choi, J.; Sherman, E.; Youssef, I.; Kang, J. J.; Zakeri, K.; Yu, Y.; Chen, L.; Shamseddine, A.; McBride, S.; Riaz, N.; more...
    International Journal of Radiation Oncology, Biology, Physics (2024)

    Fulltext@MSK | Save
  • HB-200 arenavirus-based immunotherapy plus pembrolizumab as first-line treatment of patients with recurrent/metastatic HPV16-positive head and neck cancer: Updated results
    Meeting Abstract

    Ho, A. L.; Nabell, L.; Neupane, P. C.; Posner, M. R.; Yilmaz, E.; Niu, J.; Naqash, A. R.; Pearson, A. T.; Wong, S. J.; Nieva, J. J.; more...
    Journal of Clinical Oncology (2024)

    Fulltext@MSK | Save